danthron has been researched along with anthralin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (61.54) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loewengart, G; Maté, U; Melchionne, S; Roth, D; Rusch, GM; Segal, A; Seidman, I; Smith, A; Tseng, SS; Van Duuren, BL | 1 |
| Gawlik, I; Huang, HS; Müller, K; Prinz, H; Ziereis, K | 1 |
| Breu, K; Müller, K; Reindl, H | 2 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Christophers, E; Falsafi, M; Mrowietz, U; Schröder, JM | 1 |
| Arenberger, P; Gross, E; Kemény, L; Ruzicka, T | 1 |
| Chignell, CF; Dabestani, R; Hall, RD; Sik, RH | 1 |
| Grangeret, M; Jacques, Y; Reichert, U; Schmidt, R | 1 |
| Cheah, IC; Finnin, BC; Pappas, A; Reed, BL; Sitaram, BR; Thi, NL | 1 |
| Forbes, DR; Grattan, CE; Green, PG; Kennedy, CT | 1 |
| Christophers, E; Kosfeld, U; Schröder, JM | 1 |
| Schröder, JM | 1 |
| Pfeifer, RW; Si, EC; Yim, GK | 1 |
| Haarala, J; Halmekoski, J; Taskinen, J; Wartiovaara, E | 1 |
| Detmar, M; Müller, R; Naumann, E; Orfanos, CE | 1 |
| Forbes, DR; Green, PG; Kennedy, CT | 1 |
| Kubka, KD; Mayer, KK; Plumier, E; Rosmarinowski, J; Runne, U; Safar, GJ; Schultz-Amling, W; Wiegrebe, W | 1 |
| Bedord, CJ; Wagner, BM; Young, JM | 1 |
| Puschmann, M; Schmersahl, P | 1 |
| Clark, JM; Hanawalt, PC | 2 |
| Bloch, U; Krebs, A; Schaltegger, A | 1 |
| Arenberger, P; Kemény, L; Michel, G; Ruzicka, T | 1 |
| Gawlik, I; Müller, K | 1 |
| Hilker, M; Pankewitz, F | 1 |
26 other study(ies) available for danthron and anthralin
| Article | Year |
|---|---|
Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
Topics: Animals; Anthracenes; Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Female; Metals; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Skin Neoplasms | 1978 |
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonate 5-Lipoxygenase; Cattle; Cell Division; Humans; Keratinocytes; Leukocytes, Mononuclear; Lipoxygenase Inhibitors; Oxidants; Psoriasis; Sensitivity and Specificity; Structure-Activity Relationship | 1997 |
Heterocyclic substituted anthralin derivatives as inhibitors of keratinocyte growth and inducers of differentiation.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Differentiation; Cell Division; Cell Line; Cell Membrane; Deoxyribose; Heterocyclic Compounds; Humans; Keratinocytes; Molecular Structure; Psoriasis | 2001 |
Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
Topics: Acetanilides; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Division; Cell Line; Cell Membrane; Humans; Keratinocytes; Leukotriene B4; Oxidation-Reduction; Psoriasis; Structure-Activity Relationship | 2001 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of human monocyte functions by anthralin.
Topics: Acetone; Anthralin; Anthraquinones; Cell Degranulation; Chemotaxis, Leukocyte; Depression, Chemical; Glucuronidase; Humans; Monocytes; Respiratory Burst; Superoxides | 1992 |
Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Anthralin; Anthraquinones; Cell Line; Down-Regulation; Epidermis; Humans; Hydroxyeicosatetraenoic Acids; Psoriasis; Receptors, Cell Surface; Receptors, Eicosanoid | 1991 |
Spectroscopic studies of cutaneous photosensitizing agents--XV. Anthralin and its oxidation product 1,8-dihydroxyanthraquinone.
Topics: Anthralin; Anthraquinones; Free Radicals; Humans; Molecular Structure; Oxygen; Photochemistry; Radiation-Sensitizing Agents; Singlet Oxygen; Skin | 1990 |
Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes.
Topics: Anthracenes; Anthralin; Anthraquinones; Antimycin A; Carbon Dioxide; Cell Membrane; Cells, Cultured; DNA Replication; Dose-Response Relationship, Drug; Epidermal Cells; Epidermis; Glucose; Glutamine; Humans; Keratins; Mitochondria; Mitomycin; Mitomycins; Proteins; Thymidine | 1985 |
Normal-phase and reversed-phase liquid chromatographic techniques for the determination of dithranol and its degradation products.
Topics: Anthralin; Anthraquinones; Chromatography, High Pressure Liquid; Ointments; Spectrophotometry, Ultraviolet | 1989 |
Patch testing with dithranol and its degradation products.
Topics: Anthralin; Anthraquinones; Drug Eruptions; Humans; Oxidation-Reduction; Patch Tests | 1988 |
Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.
Topics: Anthracenes; Anthralin; Anthraquinones; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Cytoplasmic Granules; Dose-Response Relationship, Drug; Glucuronidase; Humans; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Immunologic; Superoxides | 1985 |
Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
Topics: Anthralin; Anthraquinones; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Calcimycin; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophils; Oxidation-Reduction | 1986 |
Anthralin, a non-phorbol tumor promoter, fails to inhibit metabolic cooperation in mutant human fibroblasts, but inhibits phytohemagglutinin-induced lymphocyte blastogenesis in vitro.
Topics: Animals; Anthralin; Anthraquinones; Carcinogens; Cell Communication; Female; Fibroblasts; In Vitro Techniques; Lymphocyte Activation; Male; Mice; Microtubules; Phytohemagglutinins; Rats; Rats, Inbred Strains; Spleen | 1988 |
Oxidation of antipsoriatic 10-acyldithranol derivatives and dithranol to 1,8-dihydroxyanthraquinone.
Topics: Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Psoriasis | 1988 |
[Stability of cignolin (dithranol) in ointments containing tar with and without the addition of salicylic acid. Oxidation to danthron and dithranol dimer].
Topics: Anthralin; Anthraquinones; Chromatography, High Pressure Liquid; Coal Tar; Drug Stability; Humans; Ointments; Oxidation-Reduction; Salicylates; Structure-Activity Relationship | 1987 |
Anthralin stability in various vehicles.
Topics: Anthralin; Anthraquinones; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Ointments; Pharmaceutic Aids; Salicylates; Salicylic Acid; Time Factors | 1987 |
Experimental contribution to the dithranol-brown problem.
Topics: Anthracenes; Anthralin; Anthraquinones; Hot Temperature; Humans; Mass Spectrometry; Psoriasis; Skin | 1985 |
Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro.
Topics: Animals; Anthracenes; Anthralin; Anthraquinones; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Epidermis; Female; Humans; Lipoxygenase Inhibitors; Male; Mice; Naphthoquinones; Prostaglandin-Endoperoxide Synthases; Psoriasis | 1983 |
[Side effects of anthralin and its 2 main impurities on healthy skin].
Topics: Anthracenes; Anthralin; Anthraquinones; Dose-Response Relationship, Drug; Erythema; Humans; Oxidation-Reduction; Skin | 1983 |
Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells.
Topics: Anthracenes; Anthralin; Anthraquinones; Cell Line; DNA Repair; DNA Replication; DNA, Superhelical; Electrophoresis, Agar Gel; Humans; In Vitro Techniques | 1982 |
On the stability of some antipsoriatic active anthralin (dithranol) derivatives.
Topics: Anthracenes; Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Drug Stability; Humans; Psoriasis | 1982 |
Inhibition of DNA replication and repair cultured humans cells by anthralin or danthron.
Topics: Anthracenes; Anthralin; Anthraquinones; Cell Line; DNA Repair; DNA Replication; Glioma; Humans | 1981 |
Down-regulation of epidermal growth factor receptors by dithranol.
Topics: Anthralin; Anthraquinones; Cell Line; Dose-Response Relationship, Drug; Epidermis; ErbB Receptors; Humans; Psoriasis; Radioligand Assay | 1993 |
Inactivation of mouse epidermal 12-lipoxygenase by anthralin--implications for the role of oxygen radicals.
Topics: Animals; Anthracenes; Anthralin; Anthraquinones; Antioxidants; Catalase; Epidermis; Free Radical Scavengers; Free Radicals; Lipoxygenase Inhibitors; Mice; Oxygen; Superoxide Dismutase | 1996 |
Defensive components in insect eggs: are anthraquinones produced during egg development?
Topics: Animals; Anthracenes; Anthralin; Anthraquinones; Coleoptera; Female; Gas Chromatography-Mass Spectrometry; Larva; Oviposition; Ovum | 2006 |